ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

March 23, 2001

Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer

November 26, 2010

NIOSH To Fund 21 Projects With NCI Money

February 25, 1977

Roche Markets CMV Test in Europe

April 29, 2011

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

May 1, 2009

Data Falsification Charge To Be Aired

June 27, 1980